Switching from Mounjaro to Ozempic: What to Know About the Transition

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, meaning it acts on two appetite-regulating pathways. Ozempic (semaglutide) is a GLP-1 receptor agonist only, acting on one of those same pathways. Both are prescription-only, once-weekly injectable medicines, but their mechanisms are not identical — which is why the experience of moving from one to the other is not simply a like-for-like swap.

What some people commonly report when switching

When transitioning between medicines in this class, some people report a temporary shift in appetite or food-noise levels as their body adjusts to a different mechanism. Others notice changes in gastrointestinal symptoms — such as nausea, bloating, or constipation — that may differ in pattern or intensity from what they experienced on Mounjaro. These are commonly reported observations, not a guarantee of what you personally will experience.

Timing and dose equivalence during a switch are decisions that belong entirely with your prescriber. There is no standard self-managed crossover protocol you should follow independently — your prescriber will take into account your full medical history, the dose you were on, and the dose to start on with the new medicine.

Switching specifically for weight loss

If the switch is being considered in the context of weight management, it is worth knowing that progress on any GLP-1 medicine is individual and non-linear. Some people switching from Mounjaro to Ozempic for weight loss notice differences in how their appetite and food choices feel; others find the experience broadly similar. Tracking your symptoms, weight, and wellbeing consistently through any medicine change helps you and your prescriber understand how the transition is going.

For more on what side effects can look like on Mounjaro before or after a switch, see our overview of Mounjaro side effects. If your prescriber has discussed moving to Wegovy (also semaglutide) rather than Ozempic, you may also find it useful to read about switching from Mounjaro to Wegovy and the dosage considerations when switching from Mounjaro to Wegovy, as the active substance is the same.

When you move from one medicine to another, having a clear record of how you feel day to day becomes especially valuable. GLP Trackr's side-effect tracker lets you log symptoms — nausea, fatigue, appetite changes, digestive symptoms — and see how they shift over time, giving you something concrete to bring to your next prescriber appointment rather than trying to recall how the first two weeks felt.

Alongside side-effect logging, the dose and injection logging feature means you have a reliable record of when each injection happened, at what strength, and at which site — useful context for any conversation with your prescriber about how the new medicine is settling in. You can also use the daily check-in to capture mood, energy, and food-noise levels, so the full picture of your transition is in one place rather than scattered across memory.

If you want to understand more about the comparison between these two medicines from an informational standpoint, the page on whether you can switch from Mounjaro to Ozempic covers the key factual points.

Important: any decision about switching medicines, the timing of a switch, or the dose to start on belongs with your prescriber or doctor — GLP Trackr helps you record your journey so those conversations are informed, but it is not a substitute for clinical guidance. If you experience symptoms that feel severe, persistent, or worrying after a medicine change, contact your healthcare professional promptly.

Logging your transition in GLP Trackr gives you a clear, honest record to share with your prescriber. Download free on the App Store or Google Play — your first 7 days are free to try.